Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Med J Malaysia ; 76(3): 318-325, 2021 05.
Article in English | MEDLINE | ID: mdl-34031329

ABSTRACT

INTRODUCTION: Microscopic colitis (MC) is a well-recognised cause of chronic diarrhoea in Western countries. It is classically associated with normal endoscopic findings and a higher prevalence among patients with autoimmune disease. Local information regarding this disease remains scarce. We identified patients diagnosed with MC over a five-year period, and then proceeded to analyse the clinical characteristics of these cases. MATERIALS AND METHODS: A retrospective study was conducted by identifying all histologically confirmed colitis cases diagnosed at Hospital Universiti Sains Malaysia from January 2015 until December 2019. Clinicodemographic data was retrieved from case notes of patients. RESULTS: Of the 299 cases with histological colitis, 23 (7.7%) were initially identified as MC. Two cases had incomplete data, while two others were excluded as the diagnoses were revised to inflammatory bowel disease. An incidence of 14 MC cases/1000 case-year was obtained using the 21 MC cases seen within the five-year period. MC subtypes for the 19 analysed cases i.e., lymphocytic colitis and collagenous colitis accounted for 13 (68.4%) and 6 (31.6%) cases, respectively. Eleven patients (57.9%) were females (M:F ratio 1:1.5) with a median age of 51 years. Only nine (47.3%) presented with diarrhoea; one subject (5.4%) had an autoimmune condition (Hashimoto thyroiditis). Normal endoscopic findings were found in 89.5% of patients. CONCLUSION: Approximately half of the subjects in our study who had histologically confirmed MC did not present with diarrhoea. Adequate biopsy samples despite normal colonoscopy findings are important in order to not miss the diagnosis of MC.


Subject(s)
Colitis, Lymphocytic , Colitis, Microscopic , Biopsy , Colitis, Microscopic/diagnosis , Colitis, Microscopic/epidemiology , Colonoscopy , Female , Humans , Middle Aged , Retrospective Studies , Tertiary Care Centers
2.
BMC Cancer ; 19(1): 970, 2019 Oct 21.
Article in English | MEDLINE | ID: mdl-31638925

ABSTRACT

BACKGROUND: Neuroblastoma (NB) is a paediatric tumour of the sympathetic nervous system. Half of all cases are defined high-risk with an overall survival less than 40% at 5 years from diagnosis. The lack of in vitro models able to recapitulate the intrinsic heterogeneity of primary NB tumours has hindered progress in understanding disease pathogenesis and therapy response. METHODS: Here we describe the establishment of 6 patient-derived organoids (PDOs) from cells of NB tumour biopsies capable of self-organising in a structure resembling the tissue of origin. RESULTS: PDOs recapitulate the histological architecture typical of the NB tumour. Moreover, PDOs expressed NB specific markers such as neural cell adhesion molecules, NB84 antigen, synaptophysin (SYP), chromogranin A (CHGA) and neural cell adhesion molecule NCAM (CD56). Analyses of whole genome genotyping array revealed that PDOs maintained patient-specific chromosomal aberrations such as MYCN amplification, deletion of 1p and gain of chromosome 17q. Furthermore, the PDOs showed stemness features and retained cellular heterogeneity reflecting the high heterogeneity of NB tumours. CONCLUSIONS: We were able to create a novel preclinical model for NB exhibiting self-renewal property and allowing to obtain a reservoir of NB patients' biological material useful for the study of NB molecular pathogenesis and to test drugs for personalised treatments.


Subject(s)
Autonomic Nervous System Diseases/genetics , Autonomic Nervous System Diseases/pathology , Models, Biological , Neuroblastoma/genetics , Neuroblastoma/pathology , Organoids/pathology , Autonomic Nervous System Diseases/metabolism , Biomarkers, Tumor/metabolism , Biopsy , Child , Child, Preschool , Chromogranin A/metabolism , Chromosome Aberrations , Gene Amplification/genetics , Humans , Infant , N-Myc Proto-Oncogene Protein/genetics , Neuroblastoma/metabolism , Organoids/metabolism , Receptors, G-Protein-Coupled/metabolism , Synaptophysin/metabolism
3.
Malays J Pathol ; 41(1): 33-39, 2019 Apr.
Article in English | MEDLINE | ID: mdl-31025635

ABSTRACT

INTRODUCTION: Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is an important component of the IGF system that regulates insulin resistance-related to tumour development. The aim of this study is to investigate the expression of IGFBP-rP1 among female cancer patients who are known or not known to have Type 2 Diabetes Mellitus (T2DM). MATERIALS AND METHODS: Using a cross-sectional design, cases of ovarian and breast cancer with clinical status of T2DM were selected over a 10-year period in Hospital Universiti Sains Malaysia. Immunohistochemical staining for IGFBP-rP1 was performed on paraffin-embedded tissues and the results were correlated with the patient's demographic and clinicopathological data. RESULTS: A total of 152 breast cancer patients were recruited into the current study with 33.5% (51/152) patients were positive T2DM. Most of the breast cancer patients with T2DM were IGFBP-rP1-negative (66.7%, 34/51). The IGFBP-rP1 expression was significantly difference between breast cancer subjects with and without T2DM (p<0.001). There was no significant association of IGFBP-rP1 expression with data on the demographic and clinicopathological profiles of patients with breast cancer. Meanwhile, positive IGFBP-rP1 expression was evident in 44 out of 108 (40.74%) ovarian cancer cases. Among these cases, 36 were T2DM. In contrast to breast cancer cases, IGFBP-rP1 was mostly expressed among ovarian cancer patients with T2DM (66.7%, 24/36, p < 0.001). However, the -positive expression was not significantly associated with any sociodemographic and clinicopathological features of ovarian cancers. CONCLUSIONS: Majority of breast cancer patients with T2DM did not express IGFBP-rP1. In contrast, majority of the ovarian cancer patients with T2DM expressed IGFBP-rP1.


Subject(s)
Breast Neoplasms/complications , Diabetes Mellitus, Type 2/complications , Insulin-Like Growth Factor Binding Proteins/biosynthesis , Ovarian Neoplasms/complications , Adult , Aged , Breast Neoplasms/metabolism , Cross-Sectional Studies , Female , Humans , Middle Aged , Ovarian Neoplasms/metabolism
4.
Malays Fam Physician ; 13(3): 40-43, 2018.
Article in English | MEDLINE | ID: mdl-30800234

ABSTRACT

Cervical vagal schwannoma is an uncommon, benign neoplasm. It is usually asymptomatic and presents as a painless, palpable mass in the neck. However, large schwannomas can cause dysphagia, dysphonia or dyspnea as a result of compression. We report a case of an extremely rare complication of vagal schwannoma in which neck palpation induced the patient to cough. As the patient refused any surgical intervention, conservative management was used.

5.
BMC Cancer ; 16(1): 886, 2016 11 14.
Article in English | MEDLINE | ID: mdl-27842508

ABSTRACT

BACKGROUND: Rhabdomyosarcoma (RMS), which can be classified as embryonal RMS (ERMS) and alveolar RMS (ARMS), represents the most frequent soft tissue sarcoma in the pediatric population; the latter shows greater aggressiveness and metastatic potential with respect to the former. Epigenetic alterations in cancer include DNA methylation changes and histone modifications that influence overall gene expression patterns. Different tumor subtypes are characterized by distinct methylation signatures that could facilitate early disease detection and greater prognostic accuracy. METHODS: A genome-wide approach was used to examine methylation patterns associated with different prognoses, and DNA methylome analysis was carried out using the Agilent Human DNA Methylation platform. The results were validated using bisulfite sequencing and 5-aza-2'deoxycytidine treatment in RMS cell lines. Some in vitro functional studies were also performed to explore the involvement of a target gene in RMS tumor cells. RESULTS: In accordance with the Intergroup Rhabdomyosarcoma Study (IRS) grouping, study results showed that distinct methylation patterns distinguish RMS subgroups and that a cluster of protocadherin genes are hypermethylated in metastatic RMS. Among these, PCDHA4, whose expression was decreased by DNA methylation, emerged as a down-regulated gene in the metastatic samples. As PCDHA4-silenced cells have a significantly higher cell proliferation rate paralleled by higher cell invasiveness, PCDHA4 seems to behave as a tumor suppressor in metastatic RMS. CONCLUSION: Study results demonstrated that DNA methylation patterns distinguish between metastatic and non-metastatic RMS and suggest that epigenetic regulation of specific genes could represent a novel therapeutic target that could enhance the efficiency of RMS treatments.


Subject(s)
Cell Adhesion Molecules, Neuronal/genetics , DNA Methylation , Gene Expression Regulation, Neoplastic , Neuropeptides/genetics , Receptors, Cell Surface/genetics , Rhabdomyosarcoma/genetics , Rhabdomyosarcoma/pathology , Azacitidine/analogs & derivatives , Azacitidine/pharmacology , Biopsy , Cell Line, Tumor , Cluster Analysis , Cytidine Triphosphate/analogs & derivatives , Cytidine Triphosphate/pharmacology , Epigenesis, Genetic/drug effects , Gene Expression Profiling , Gene Expression Regulation, Neoplastic/drug effects , Genome-Wide Association Study , Humans , Hydroxamic Acids/pharmacology , Neoplasm Metastasis , Promoter Regions, Genetic , Protocadherins , Transcriptome
6.
Br J Cancer ; 109(12): 3084-91, 2013 Dec 10.
Article in English | MEDLINE | ID: mdl-24149177

ABSTRACT

BACKGROUND: Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase aberrantly expressed in cancer, but its clinical and functional importance remain controversial. Mutation or amplification of ALK, as well as its expression levels assessed by conventional immunohistochemistry methods, has been linked to prognosis in cancer, although with potential bias because of the semi-quantitative approaches. Herein, we measured ALK mRNA expression in rhabdomyosarcoma (RMS) and determined its clinical impact on patients' stratification and outcome. METHODS: Specimens were obtained from RMS patients and cell lines, and ALK expression was analysed by quantitative RT-PCR, western blotting, IHC, and copy number analysis. RESULTS: High ALK mRNA expression was detected in the vast majority of PAX3/7-FOXO1-positive tumours, whereas PAX3/7-FOXO1-negative RMS displayed considerably lower amounts of both mRNA and protein. Notably, ALK mRNA distinguished unfavourable PAX3/7-FOXO1-positive tumours from PAX3/7-FOXO1-negative RMS (P<0.0001), and also correlated with larger tumour size (P<0.05) and advanced clinical stage (P<0.01), independently of fusion gene status. High ALK mRNA levels were of prognostic relevance by Cox univariate regression analysis and correlated with increased risk of relapse (P=0.001) and survival (P=0.01), whereas by multivariate analysis elevated ALK mRNA expression resulted a negative prognostic marker when clinical stage was not included. CONCLUSION: Quantitative assessment of ALK mRNA expression helps to improve risk stratification of RMS patients and identifies tumours with adverse biological characteristics and aggressive behaviour.


Subject(s)
RNA, Messenger/biosynthesis , Receptor Protein-Tyrosine Kinases/biosynthesis , Rhabdomyosarcoma/enzymology , Anaplastic Lymphoma Kinase , Cell Line, Tumor , Child , Female , Gene Expression , Humans , Immunohistochemistry , Male , Prognosis , RNA, Messenger/genetics , Receptor Protein-Tyrosine Kinases/genetics , Rhabdomyosarcoma/genetics , Rhabdomyosarcoma/pathology , Survival Analysis
7.
BMJ Case Rep ; 20132013 Jun 21.
Article in English | MEDLINE | ID: mdl-23813511

ABSTRACT

Primary primitive neuroectodermal tumour (PNET) and extraskeletal Ewing's sarcoma belongs to the Ewing's family of tumours. Primary tumours arising from breast are very rare. There are only a few case reports published on primary extraskeletal Ewing's sarcoma and PNET arising from breast. We present an extremely rare case of an inoperable primary Ewing's sarcoma arising from left breast with contralateral breast, lymphatic and lung metastasis.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms/diagnosis , Neuroectodermal Tumors, Primitive/diagnosis , Sarcoma, Ewing/diagnosis , Adult , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , Cyclophosphamide/administration & dosage , Cyclophosphamide/therapeutic use , Diagnosis, Differential , Doxorubicin/administration & dosage , Doxorubicin/therapeutic use , Fatal Outcome , Female , Humans , Neuroectodermal Tumors, Primitive/drug therapy , Neuroectodermal Tumors, Primitive/pathology , Sarcoma, Ewing/drug therapy , Sarcoma, Ewing/pathology , Tomography, X-Ray Computed , Vincristine/administration & dosage , Vincristine/therapeutic use
9.
Article in Russian | MEDLINE | ID: mdl-19425297

ABSTRACT

The results of the dynamic study of patients with epileptic seizures in chronic and acute cerebral vascular pathology are presented. Various methods of structural and functional neurovisualization--magnetic resonance tomography using perfusion- and diffusion-weighted imaging, proton magnetic resonance spectroscopy, positron emission tomography, single photon emission computed tomography were used. Based on the results obtained in the study, the authors discuss etiopathogenetic variants of the development of these seizures and new possible approaches to the complex treatment besides the administration of antiepileptic medications.


Subject(s)
Cerebrovascular Disorders/complications , Magnetic Resonance Imaging/methods , Seizures/diagnosis , Aged , Cerebrovascular Disorders/diagnosis , Diagnosis, Differential , Humans , Male , Seizures/etiology
10.
Community Eye Health ; 14(40): 58-9, 2001.
Article in English | MEDLINE | ID: mdl-17491934
11.
Ophthalmology ; 106(11): 2126-30, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10571348

ABSTRACT

PURPOSE: To highlight the association of posterior osseous and/or cartilaginous ocular choristomas with epibulbar choristomas and the nevus sebaceus of Jadassohn. DESIGN: Small case series. PARTICIPANTS: Four patients with the organoid nevus syndrome. METHODS: Clinical and histopathologic studies in four patients with epibulbar lesions and nevus sebaceus of Jadassohn. MAIN OUTCOME MEASURES: Ophthalmoscopic findings of peripapillary lesions. Computed tomographic and ultrasonographic characteristic of posterior scleral lesions. Ocular histopathologic findings in one globe from one of the study subjects. RESULTS: Three patients had the triad of posterior osseous/cartilaginous ocular choristomas, anterior epibulbar choristomas, and nevus sebaceus of Jadassohn and one patient had anterior epibulbar choristomas and posterior osseous/cartilaginous ocular choristomas. Ultrasonography and computed tomography were valuable in detecting scleral ossification or epibulbar cartilage or both. The ophthalmoscopic findings were similar to those of a choroidal osteoma. CONCLUSIONS: The presence of posterior osseous/cartilaginous ocular choristomas in a patient with epilepsy or epibulbar lesions or both suggests the diagnosis of nevus sebaceus of Jadassohn. Osseous/cartilaginous ocular choristomas should be suspected in patients with nevus sebaceus of Jadassohn and peripapillary hypopigmented fundus lesions.


Subject(s)
Cartilage , Choristoma/complications , Eye Abnormalities/complications , Eye Neoplasms/complications , Nevus, Pigmented/complications , Scleral Diseases/complications , Sebaceous Gland Neoplasms/complications , Seizures/complications , Child , Child, Preschool , Choristoma/diagnosis , Choristoma/pathology , Eye Abnormalities/diagnosis , Eye Abnormalities/pathology , Eye Neoplasms/diagnosis , Eye Neoplasms/pathology , Female , Humans , Magnetic Resonance Imaging , Male , Nevus, Pigmented/diagnosis , Nevus, Pigmented/pathology , Ossification, Heterotopic/complications , Ossification, Heterotopic/pathology , Scleral Diseases/diagnosis , Scleral Diseases/pathology , Sebaceous Gland Neoplasms/diagnosis , Sebaceous Gland Neoplasms/pathology , Seizures/diagnosis , Seizures/pathology , Syndrome , Tomography, X-Ray Computed , Ultrasonography
12.
SELECTION OF CITATIONS
SEARCH DETAIL
...